Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Viguié F[au]:

Mutation in TET2 in myeloid cancers. Delhommeau F et al. N Engl J Med. (2009)

Atlas of genetics and cytogenetics in oncology and haematology in 2013. Huret JL et al. Nucleic Acids Res. (2013)

Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia. Kempf E et al. Leuk Res. (2014)

Search results

Items: 1 to 50 of 63

1.

Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia.

Kempf E, Hirsch P, Labopin M, Viguié F, Isnard F, Tang R, Marzac C, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Dec;38(12):1425-9. doi: 10.1016/j.leukres.2014.09.013. Epub 2014 Oct 7.

PMID:
25443887
2.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.

Hirsch P, Labopin M, Viguié F, Perot C, Isnard F, Mamez AC, Bilhou-Nabera C, Marzac C, Delhommeau F, Lapusan S, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Aug;38(8):907-12. doi: 10.1016/j.leukres.2014.05.021. Epub 2014 Jun 4.

PMID:
24957411
3.

Atlas of genetics and cytogenetics in oncology and haematology in 2013.

Huret JL, Ahmad M, Arsaban M, Bernheim A, Cigna J, Desangles F, Guignard JC, Jacquemot-Perbal MC, Labarussias M, Leberre V, Malo A, Morel-Pair C, Mossafa H, Potier JC, Texier G, Viguié F, Yau Chun Wan-Senon S, Zasadzinski A, Dessen P.

Nucleic Acids Res. 2013 Jan;41(Database issue):D920-4. doi: 10.1093/nar/gks1082. Epub 2012 Nov 17.

4.

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study.

Kosmider O, Delabesse E, de Mas VM, Cornillet-Lefebvre P, Blanchet O, Delmer A, Recher C, Raynaud S, Bouscary D, Viguié F, Lacombe C, Bernard OA, Ifrah N, Dreyfus F, Fontenay M; GOELAMS Investigators.

Haematologica. 2011 Jul;96(7):1059-63. doi: 10.3324/haematol.2011.040840. Epub 2011 Apr 20.

5.

Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide.

Park S, Vassilieff D, Bardet V, Viguié F, Dreyfus F.

Leukemia. 2010 Nov;24(11):1960-2. doi: 10.1038/leu.2010.183. Epub 2010 Aug 19. No abstract available.

PMID:
20724986
6.

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

Kosmider O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V, Picard F, Viguié F, Quesnel B, Beyne-Rauzy O, Solary E, Vey N, Hunault-Berger M, Fenaux P, Mansat-De Mas V, Delabesse E, Guardiola P, Lacombe C, Vainchenker W, Preudhomme C, Dreyfus F, Bernard OA, Birnbaum D, Fontenay M; Groupe Francophone des Myélodysplasies.

Blood. 2009 Oct 8;114(15):3285-91. doi: 10.1182/blood-2009-04-215814. Epub 2009 Aug 7.

7.

Mutation in TET2 in myeloid cancers.

Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

8.

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.

Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D, Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P.

J Exp Med. 2008 Oct 27;205(11):2499-506. doi: 10.1084/jem.20080285. Epub 2008 Oct 20.

9.

PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.

Park S, Chapuis N, Bardet V, Tamburini J, Gallay N, Willems L, Knight ZA, Shokat KM, Azar N, Viguié F, Ifrah N, Dreyfus F, Mayeux P, Lacombe C, Bouscary D.

Leukemia. 2008 Sep;22(9):1698-706. doi: 10.1038/leu.2008.144. Epub 2008 Jun 12.

PMID:
18548104
10.

Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy.

Richebourg S, Eclache V, Perot C, Portnoi MF, Van den Akker J, Terré C, Maareck O, Soenen V, Viguié F, Laï JL, Andrieux J, Corm S, Roche-Lestienne C; Fi-LMC Group.

Cancer Genet Cytogenet. 2008 Apr 15;182(2):95-102. doi: 10.1016/j.cancergencyto.2008.01.005.

PMID:
18406870
11.

TRAF4 overexpression is a common characteristic of human carcinomas.

Camilleri-Broët S, Cremer I, Marmey B, Comperat E, Viguié F, Audouin J, Rio MC, Fridman WH, Sautès-Fridman C, Régnier CH.

Oncogene. 2007 Jan 4;26(1):142-7. Epub 2006 Jun 26.

PMID:
16799635
12.

Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?

Viguié F, Aboura A, Bouscary D, Ramond S, Delmer A, Tachdjian G, Marie JP, Casadevall N.

Leukemia. 2005 Aug;19(8):1411-5.

PMID:
15920487
13.

A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.

Eclache V, Viguie F, Frocrain C, Cassinat B, Chomienne C, Cymbalista F, Fenaux P.

Cancer Genet Cytogenet. 2005 May;159(1):69-73.

PMID:
15860361
14.

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, Mozziconacci MJ, Maarek O, Mossafa H, Auger N, Dastugue N, Talmant P, Van den Akker J, Leonard C, N'Guyen Khac F, Mugneret F, Viguié F, Lafage-Pochitaloff M, Bastie JN, Roux GL, Nicolini F, Maloisel F, Vey N, Laurent G, Recher C, Vigier M, Yacouben Y, Giraudier S, Vernant JP, Salles B, Roussi J, Castaigne S, Leymarie V, Flandrin G, Lessard M; France Intergroupe pour la Leucemie Myeloide Chronique.

Leukemia. 2004 Aug;18(8):1340-6.

PMID:
15190256
15.

Isodicentric/pseudoisodicentric chromosome 21 amplification in four cases of acute myelocytic leukemia or myelodysplasia.

Viguié F, Aboura A, Bouscary D, Guesnu M, Baumelou E, Dreyfus F, Casadevall N, Tachdjian G.

Cancer Genet Cytogenet. 2002 Oct 1;138(1):80-4.

PMID:
12419591
16.

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.

Pene F, Claessens YE, Muller O, Viguié F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D.

Oncogene. 2002 Sep 26;21(43):6587-97.

17.
18.

Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.

Park S, Picard F, Azgui Z, Viguie F, Merlat A, Guesnu M, Leblond V, Dreyfus F.

Leuk Res. 2002 May;26(5):423-9.

PMID:
11916513
19.

Cytogenetic analysis from DNA by comparative genomic hybridization.

Tachdjian G, Aboura A, Lapierre JM, Viguié F.

Ann Genet. 2000 Jul-Dec;43(3-4):147-54. Review.

PMID:
11164197
20.

Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature.

Zompi S, Legrand O, Bouscary D, Blanc CM, Picard F, Casadevall N, Dreyfus F, Marie JP, Viguié F.

Br J Haematol. 2000 Sep;110(3):610-3. Review.

PMID:
10997972
21.

Pure red cell aplasia associated with myelodysplastic syndromes.

Park S, Merlat A, Guesnu M, Picard F, Viguié F, Vassilieff D, Dreyfus F.

Leukemia. 2000 Sep;14(9):1709-10. No abstract available.

PMID:
10995022
22.

Submicroscopic insertion of RARalpha gene into chromosome 15 in two cases of acute promyelocytic leukemia.

Viguié F, Aboura A, Ramond S, Bouscary D, Baudard M, Chomienne C, Marie JP.

Cancer Genet Cytogenet. 2000 Jun;119(2):162-4.

PMID:
10867154
23.

Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group.

Bernstein J, Dastugue N, Haas OA, Harbott J, Heerema NA, Huret JL, Landman-Parker J, LeBeau MM, Leonard C, Mann G, Pages MP, Perot C, Pirc-Danoewinata H, Roitzheim B, Rubin CM, Slociak M, Viguie F.

Leukemia. 2000 Jan;14(1):216-8. Review. No abstract available.

PMID:
10637500
24.

Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera.

Bouscary D, Jondeau K, Viguié F, Zompi S, Fontenay-Roupie M, Quarre MC, Vassilief D, Dreyfus F, Casadevall N.

Leuk Lymphoma. 1999 May;33(5-6):607-11.

PMID:
10342591
25.

Pentasomy 13q in a case of acute myelogenous leukemia (Mo).

Ramond S, Cacheux V, Ciaudo M, Cadiou M, Perrot JY, Delmer A, Viguié F, Zittoun R, Marie JP.

Cancer Genet Cytogenet. 1998 Nov;107(1):73-5.

PMID:
9809039
26.

Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.

Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, Ramond S, Viguié F, Marie JP, Zittoun R.

Br J Haematol. 1998 Jan;100(1):147-55.

PMID:
9450804
27.

Different proximal and distal rearrangements of chromosome 7q associated with holoprosencephaly.

Benzacken B, Siffroi JP, Le Bourhis C, Krabchi K, Joyé N, Maschino F, Viguié F, Soulié J, Gonzales M, Migné G, Bucourt M, Encha-Razavi F, Carbillon L, Taillemite JL.

J Med Genet. 1997 Nov;34(11):899-903.

28.

Prognostic factors in elderly acute lymphoblastic leukaemia.

Legrand O, Marie JP, Marjanovic Z, Cadiou M, Blanc C, Ramond S, Viguié F, Perrot JY, Zittoun R.

Br J Haematol. 1997 Jun;97(3):596-602.

PMID:
9207406
29.

Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias.

Fontenay-Roupie M, Bouscary D, Melle J, Viguié F, Picard F, Guesnu M, Dreyfus F.

Hematol Cell Ther. 1997 Feb;39(1):5-10.

PMID:
9088932
30.

Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment.

Hunault M, Zhou D, Delmer A, Ramond S, Viguié F, Cadiou M, Perrot JY, Levy V, Rio B, Cymbalista F, Zittoun R, Marie JP.

Ann Hematol. 1997 Feb;74(2):65-71.

PMID:
9063375
31.

Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromes.

Jondeau K, Bouscary D, Viguié F, Picard F, Melle J, Lopez I, Fontenay-Roupie M, Dreyfus F.

Leukemia. 1996 Nov;10(11):1692-5.

PMID:
8892668
32.

Budd-Chiari syndrome associated with 5q deletion and hypereosinophilia.

Zylberberg H, Valla D, Viguie F, Casadevall N.

J Clin Gastroenterol. 1996 Jul;23(1):66-8.

PMID:
8835906
33.

Unmaintained cytogenetic and molecular remission in chronic myelogenous leukaemia following treatment by interferon.

Rio B, Ramond S, Lacorte JM, Pépin D, Barbu V, Viguie F, Ajchenbaum-Cymbalista F, Lorrot M, Chambaz J, Zittoun R.

Br J Haematol. 1996 Feb;92(2):504-5. No abstract available.

PMID:
8603027
34.
35.

Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome.

Bouscary D, Fontenay-Roupie M, Chretien S, Hardy AC, Viguié F, Picard F, Melle J, Dreyfus F.

Br J Haematol. 1995 Oct;91(2):425-7.

PMID:
8547088
36.

Another case of trisomy 4 with double minute chromosomes in acute non-lymphocytic leukemia.

Ramond S, Delmer A, Cymbalista-Ajchembaum F, Cadiou M, Viguié F, Zittoun R, Dadoune JP.

Cancer Genet Cytogenet. 1995 Sep;83(2):165-7.

PMID:
7553589
37.

Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration.

Mignault GG, Latreille J, Viguié F, Richer P, Lemire F, Harsanyi Z, Stewart JH.

J Pain Symptom Manage. 1995 Aug;10(6):416-22.

PMID:
7561223
38.

Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7.

Viguié F, Prigent Y, Ramond S, Baumelou E, Cadiou M, Dreyfus F, Zittoun R.

Leukemia. 1995 Jul;9(7):1154-8.

PMID:
7630189
39.

Prognostic value of c-mpl expression in myelodysplastic syndromes.

Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguié F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F.

Leukemia. 1995 May;9(5):783-8.

PMID:
7539513
40.

Prenatal diagnosis of partial 2p trisomy by 'de novo' duplication 2p (13.1-->21). Confirmation by FISH.

Siffroi JP, Molina-Gomez D, Viguie F, Nessmann C, Dadoune JP.

Prenat Diagn. 1994 Nov;14(11):1097-9. No abstract available.

PMID:
7877961
41.

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

Baudard M, Marie JP, Cadiou M, Viguié F, Zittoun R.

Br J Haematol. 1994 Jan;86(1):82-91.

PMID:
8011551
42.

Acute myelomonocytic leukemia in a XYY man.

Bauduer F, Ramond S, Delmer A, Delmas-Marsalet B, Viguié F, Dadoune JP, Zittoun R.

Cancer Genet Cytogenet. 1993 Sep;69(2):156-7.

PMID:
8402557
43.

Expression of the c-mpl proto-oncogene in human hematologic malignancies.

Vigon I, Dreyfus F, Melle J, Viguié F, Ribrag V, Cocault L, Souyri M, Gisselbrecht S.

Blood. 1993 Aug 1;82(3):877-83.

44.

Near-haploid karyotype in a squamous cell lung carcinoma.

Drouin V, Viguié F, Debesse B.

Genes Chromosomes Cancer. 1993 Aug;7(4):209-12.

PMID:
7692946
45.

Occupational risk factors for acute leukaemia: a case-control study.

Richardson S, Zittoun R, Bastuji-Garin S, Lasserre V, Guihenneuc C, Cadiou M, Viguie F, Laffont-Faust I.

Int J Epidemiol. 1992 Dec;21(6):1063-73.

PMID:
1483810
46.

Chromosomal localization of the human protamine genes, PRM1 and PRM2, to 16p13.3 by in situ hybridization.

Viguié F, Domenjoud L, Rousseau-Merck MF, Dadoune JP, Chevaillier P.

Hum Genet. 1990 Jul;85(2):171-4.

PMID:
2370044
47.

Evaluation of clonidine suppression of opiate withdrawal reactions: a multidisciplinary approach.

Cuthill JD, Beroniade V, Salvatori VA, Viguié F.

Can J Psychiatry. 1990 Jun;35(5):377-82.

PMID:
2372746
48.

Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties.

Delmer A, Marie JP, Thevenin D, Cadiou M, Viguié F, Zittoun R.

J Clin Oncol. 1989 Jun;7(6):738-46.

PMID:
2715804
49.

Unstable translocation t(14;21) in a man, inherited as a t(13;14) in one of his daughters.

Siffroi JP, Viguie F, Romani F.

Clin Genet. 1988 Jul;34(1):15-9.

PMID:
3409535
50.

Myotonic dystrophy of Steinert: are anxiety and depression necessarily concomitants?

Cuthill J, Gattereau A, Viguié F.

Can J Psychiatry. 1988 Apr;33(3):203-6.

PMID:
3383095

Supplemental Content

Loading ...
Support Center